Cytovance_HepaLink_Digtial_032017.jpg
Cytovance® Biologics Names Dr. Yan Wang as Chief Executive Officer
31. Juli 2018 05:00 ET | Cytovance Biologics
OKLAHOMA CITY, July 31, 2018 (GLOBE NEWSWIRE) -- Cytovance® Biologics, Inc., a leading full-service biopharmaceutical contract manufacturer of mammalian and microbial biologics, names Yan Wang,...
Cytovance_HepaLink_Digtial_032017.jpg
Cytovance® Biologics Successfully Completes FDA Inspection
09. Mai 2018 05:00 ET | Cytovance Biologics
OKLAHOMA CITY, May 09, 2018 (GLOBE NEWSWIRE) -- Cytovance® Biologics, Inc., a leading full-service biopharmaceutical contract development and manufacturing services company is pleased to announce...
Cytovance_HepaLink_Digtial_032017.jpg
Cytovance® Biologics, Inc. announces completion of first batch in new state-of-the-art 1000L microbial facility
13. Februar 2018 05:00 ET | Cytovance Biologics
OKLAHOMA CITY, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Cytovance® Biologics, Inc., a leading full-service biopharmaceutical contract manufacturer of mammalian and microbial biologics, announces completion...
Cytovance_HepaLink_Digtial_032017.jpg
Cytovance® Biologics Welcomes Edwin Miranda as Vice President of Quality
15. Januar 2018 04:00 ET | Cytovance Biologics
OKLAHOMA CITY, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Cytovance® Biologics, Inc., a leading full-service biopharmaceutical contract manufacturer of mammalian and microbial biologics, announces and...
Cytovance_HepaLink_Digtial_032017.jpg
Cytovance Biologics, Inc. announces Bexion Pharmaceuticals Inc. has chosen Cytovance to manufacture the protein component and active ingredient of Bexion’s first clinical compound, BXQ-350
28. November 2017 05:00 ET | Cytovance Biologics
OKLAHOMA CITY, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cytovance Biologics, Inc. (Cytovance), a leading full-service contract development and manufacturer of mammalian and microbial biologics, today...
Cytovance_HepaLink_Digtial_032017.jpg
Cytovance® Biologics Inc. Completes Its First FDA General Inspection Of Oklahoma City, OK Facilities
24. Juli 2017 05:00 ET | Cytovance Biologics
OKLAHOMA CITY, July 24, 2017 (GLOBE NEWSWIRE) -- Cytovance hosted an unannounced FDA inspection Tuesday, July 11th 2017. The inspector conducted the inspection over an eight day period and focused...
Cytovance_HepaLink_Digtial_032017.jpg
Cytovance® Biologics Wins 2017 CMO Leadership Awards
14. März 2017 05:00 ET | Cytovance Biologics
OKLAHOMA CITY, March 14, 2017 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading CDMO who provides unparalleled support to biopharmaceutical companies to move candidate molecules from the bench to...